Cleared Traditional

K121818 - OSTEOFAB PATIENT SPECIFIC CRANIAL DEVICE

K121818 is an FDA 510(k) clearance for OSTEOFAB PATIENT SPECIFIC CRANIAL DEVICE, manufactured by Oxford Performance Materials. The device is a Class 2 Neurology device with product code GXN cleared through the Traditional 510(k) pathway after a 232-day FDA review.

K121818 · Oxford Performance Materials · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2013
Decision
232d
Days
Class 2
Risk

K121818 is an FDA 510(k) clearance for the OSTEOFAB PATIENT SPECIFIC CRANIAL DEVICE. Classified as Plate, Cranioplasty, Preformed, Non-alterable (product code GXN), Class II - Special Controls.

Submitted by Oxford Performance Materials (South Windsor, US). The FDA issued a Cleared decision on February 7, 2013 after a review of 232 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxford Performance Materials devices

FDA 510(k) Submission Details - K121818

510(k) Number K121818 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2012
Decision Date February 07, 2013
Days to Decision 232 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d slower than avg
Panel avg: 148d · This submission: 232d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXN Device Classification - Class 2, Special Controls

Product Code GXN Plate, Cranioplasty, Preformed, Non-alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXN Plate, Cranioplasty, Preformed, Non-alterable

All 41
Devices cleared under the same product code (GXN) and FDA review panel - the closest regulatory comparables to K121818.
Longeviti PMMA Static Cranial Implant
K170410 · Longeviti Neuro Solutions, LLC · Mar 2018
Patient Contoured Implant-PEEK (PCI-PEEK)
K151382 · KLS-Martin L.P. · Nov 2015
SPEEDY FLAP SYSTEM
K130447 · Jeil Medical Corporation · Dec 2014
CRAINFIX 2 TITANIUM CLAMP SYSTEM
K122353 · Aesculap, Inc. · Aug 2012
MOFICATION TO: MODIFIED PLATE DESIGN FOR BIOPLATE ZIP CRANIOTOMY FIXATION
K082175 · Bioplate, Inc. · Aug 2008
PATIENT CONTOURED MESH-PEEK (PCM-P)
K072707 · KLS-Martin L.P. · Dec 2007